Alicaway, Christel Jane .
HRN: 21-18-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2024
CEFUROXIME 1.5GM (VIAL)
07/23/2024
07/24/2024
IV
1.5g
Q8 X 3 Doses
Post Op Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes